Interleukin-2 receptor gamma-chain ribozymes
US5807743A · kind A · utility
11Cited by
5References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 3, 1996 |
| Grant date | Sep 15, 1998 |
| Priority date | — |
| Expiry date | Dec 3, 2016 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2310/122
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A nucleic acid molecule which blocks synthesis and/or expression of an IL-2R encoded RNA, wherein said nucleic acid molecule is used to treat graft rejection, an autoimmune disease, cancer, psoriasis, an allergy or other inflammatory disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.